IBDEI1D1 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24407,1,4,0)
 ;;=4^428.43
 ;;^UTILITY(U,$J,358.3,24407,1,5,0)
 ;;=5^Heart Failure,Systolic&Diastolic
 ;;^UTILITY(U,$J,358.3,24407,2)
 ;;=^328502
 ;;^UTILITY(U,$J,358.3,24408,0)
 ;;=396.3^^145^1525^10
 ;;^UTILITY(U,$J,358.3,24408,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24408,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,24408,1,5,0)
 ;;=5^Aortic and Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,24408,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,24409,0)
 ;;=429.9^^145^1525^28
 ;;^UTILITY(U,$J,358.3,24409,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24409,1,4,0)
 ;;=4^429.9
 ;;^UTILITY(U,$J,358.3,24409,1,5,0)
 ;;=5^Diastolic Dysfunction
 ;;^UTILITY(U,$J,358.3,24409,2)
 ;;=^54741
 ;;^UTILITY(U,$J,358.3,24410,0)
 ;;=453.79^^145^1525^27
 ;;^UTILITY(U,$J,358.3,24410,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24410,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,24410,1,5,0)
 ;;=5^Chr Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,24410,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,24411,0)
 ;;=453.89^^145^1525^1
 ;;^UTILITY(U,$J,358.3,24411,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24411,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,24411,1,5,0)
 ;;=5^AC Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,24411,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,24412,0)
 ;;=454.2^^145^1525^85
 ;;^UTILITY(U,$J,358.3,24412,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24412,1,4,0)
 ;;=4^454.2
 ;;^UTILITY(U,$J,358.3,24412,1,5,0)
 ;;=5^Varicose Veins w/Ulcer&Inflam
 ;;^UTILITY(U,$J,358.3,24412,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,24413,0)
 ;;=397.1^^145^1525^74
 ;;^UTILITY(U,$J,358.3,24413,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24413,1,4,0)
 ;;=4^397.1
 ;;^UTILITY(U,$J,358.3,24413,1,5,0)
 ;;=5^Rheumatic Disease Pulmonary Valve
 ;;^UTILITY(U,$J,358.3,24413,2)
 ;;=^269587
 ;;^UTILITY(U,$J,358.3,24414,0)
 ;;=397.0^^145^1525^75
 ;;^UTILITY(U,$J,358.3,24414,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24414,1,4,0)
 ;;=4^397.0
 ;;^UTILITY(U,$J,358.3,24414,1,5,0)
 ;;=5^Rheumatic Disease Tricuspid Valve
 ;;^UTILITY(U,$J,358.3,24414,2)
 ;;=^35528
 ;;^UTILITY(U,$J,358.3,24415,0)
 ;;=414.3^^145^1525^17
 ;;^UTILITY(U,$J,358.3,24415,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24415,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,24415,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,24415,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,24416,0)
 ;;=414.4^^145^1525^16
 ;;^UTILITY(U,$J,358.3,24416,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24416,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,24416,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,24416,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,24417,0)
 ;;=425.11^^145^1525^60
 ;;^UTILITY(U,$J,358.3,24417,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24417,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,24417,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,24417,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,24418,0)
 ;;=425.18^^145^1525^59
 ;;^UTILITY(U,$J,358.3,24418,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24418,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,24418,1,5,0)
 ;;=5^Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,24418,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,24419,0)
 ;;=V12.55^^145^1525^54
 ;;^UTILITY(U,$J,358.3,24419,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24419,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,24419,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,24419,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,24420,0)
 ;;=454.9^^145^1525^84
 ;;^UTILITY(U,$J,358.3,24420,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24420,1,4,0)
 ;;=4^454.9
